TTI-109 delivered TTI-101-equivalent exposure with improved tolerability and meaningful reductions in disease-relevant STAT3-driven immune cell ...

Endogenex, a clinical-stage medical device company dedicated to improving outcomes in individuals with type 2 diabetes (T2D), announced that the ReCET Clinical Study has reached full enrollment. A ...

Pivotal Phase 3 trial enrolls 850 patients, exceeding original projections Study completion on track: symptomatic data ...

A guide for finding and unlocking a Fort Storage Room, as well as completing the contracts located there in Sand: Raiders of ...

A recent study found that a combination of dietary fibers effectively alleviated chronic constipation, enhancing bowel ...

Candel Therapeutics (CADL) shifts to late-stage oncology with CAN-2409 Phase III wins and BLA catalyst. Read here for a ...

After a four-month investigation, Nature Medicine has decided to pull a viral study that linked early-day PD-1/chemo ...

People treated for aggressive melanoma now have a concrete reason to watch a single experimental combination closely. In a ...

Summary: A new study demonstrates that the BCG vaccine actively remodels the immune environment surrounding the human brain and spinal cord. By tracking older adults over 12 months, the research team ...

Data from EULAR 2026 show that next-generation CAR T- and NK cell platforms induce powerful, drug-free clinical remissions in patients with highly refractory rheumatic diseases.

AVE has made a breakthrough with a phase III insomnia trial for its soft gel cannabidiol to manage sleeplessness. ... Read ...

The findings suggest that Covid vaccines reduced the likelihood of severe illness last fall and winter.